Anastrozole Monoacid monoamide
| Product Name | Anastrozole Monoacid monoamide |
|---|---|
| Alternate Names | Anastrozole Impurities, Impurities of Anastrozole |
| CAT No. | CS-EO-00182 |
| CAS No. | 2469244-33-3 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 330.38 g/mol |
| Mol. For. | C17H22N4O3 |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Anastrozole |
| Smileys | CC(C)(C1=CC(C(C)(C)C(N)=O)=CC(CN2N=CN=C2)=C1)C(O)=O |
| Canonical Smiles | CC(C)(C1=CC(=CC(=C1)CN2C=NC=N2)C(C)(C)C(=O)O)C(=O)N |
| InchIKey | XHGMJOHNUGUJDB-UHFFFAOYSA-N |
| Inchl | InChI=1S/C17H22N4O3/c1-16(2,14(18)22)12-5-11(8-21-10-19-9-20-21)6-13(7-12)17(3,4)15(23)24/h5-7,9-10H,8H2,1-4H3,(H2,18,22)(H,23,24) |
| IUPAC | 2-[3-(1-amino-2-methyl-1-oxopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanoic acid |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Anastrozole Monoacid monoamide is a potent medication that is used in the treatment of breast cancer in postmenopausal women. It is an aromatase inhibitor that works by blocking the production of estrogen, which can fuel the growth of breast cancer cells.
Anastrozole Monoacid monoamide is typically administered orally and is available in tablet form. It is recommended that patients take the medication at the same time each day, either with or without food. The dosage of the drug is determined by the patient's medical history, age, and other factors.
The chemical structure of Anastrozole Monoacid monoamide is characterized by a monoamide group and a monoacid group. The drug has a molecular weight of 293.4 g/mol and a melting point of 81-82°C. It is a white to off-white crystalline powder that is sparingly soluble in water.
The drug is metabolized by the liver and is excreted primarily through the urine. Patients with liver or kidney disease may require dosage adjustments or monitoring of their liver and kidney function while taking Anastrozole Monoacid monoamide.
In conclusion, Anastrozole Monoacid monoamide is an effective medication for the treatment of breast cancer in postmenopausal women. It works by blocking the production of estrogen, which can fuel the growth of breast cancer cells. The drug has a unique chemical structure characterized by a monoamide group and a monoacid group and is metabolized by the liver. Patients should take the medication as prescribed by their doctor and be aware of any potential side effects or interactions with other medications.
Get an Instant Quote
Related Compounds
Anastrozole Monoamide Mononitrile | Anastrozole Mono Acid | Anastrozole EP Impurity E | Anastrozole EP Impurity I | Anastrozole USP related Impurity e | Anastrozole Isomer | Anastrozole EP Impurity C | Hydroxy Anastrozole | Anastrozole EP Impurity H | Anastrozole EP Impurity A | Anastrozole Impurity A | Di-destriazole Desmethyl Anastrozole Dimer Impurity | Anastrozole diamide |